135 related articles for article (PubMed ID: 29929445)
21. Effects of vitamin D on ovary in DHEA-treated PCOS rat model: A light and electron microscopic study.
Çelik LS; Kuyucu Y; Yenilmez ED; Tuli A; Dağlıoğlu K; Mete UÖ
Ultrastruct Pathol; 2018; 42(1):55-64. PubMed ID: 29192811
[TBL] [Abstract][Full Text] [Related]
22. Hyperandrogenism induces a proinflammatory TNFα response to glucose ingestion in a receptor-dependent fashion.
González F; Sia CL; Bearson DM; Blair HE
J Clin Endocrinol Metab; 2014 May; 99(5):E848-54. PubMed ID: 24512496
[TBL] [Abstract][Full Text] [Related]
23. Dehydroepiandrosterone to induce murine models for the study of polycystic ovary syndrome.
Motta AB
J Steroid Biochem Mol Biol; 2010 Apr; 119(3-5):105-11. PubMed ID: 20188831
[TBL] [Abstract][Full Text] [Related]
24. High level of C-type natriuretic peptide induced by hyperandrogen-mediated anovulation in polycystic ovary syndrome mice.
Wang X; Wang H; Liu W; Zhang Z; Zhang Y; Zhang W; Chen Z; Xia G; Wang C
Clin Sci (Lond); 2018 Apr; 132(7):759-776. PubMed ID: 29535265
[TBL] [Abstract][Full Text] [Related]
25. Molecular characterization of insulin resistance and glycolytic metabolism in the rat uterus.
Zhang Y; Sun X; Sun X; Meng F; Hu M; Li X; Li W; Wu XK; Brännström M; Shao R; Billig H
Sci Rep; 2016 Jul; 6():30679. PubMed ID: 27461373
[TBL] [Abstract][Full Text] [Related]
26. Perturbed ovarian and uterine glucocorticoid receptor signaling accompanies the balanced regulation of mitochondrial function and NFκB-mediated inflammation under conditions of hyperandrogenism and insulin resistance.
Hu M; Zhang Y; Guo X; Jia W; Liu G; Zhang J; Cui P; Li J; Li W; Wu X; Ma H; Brännström M; Shao LR; Billig H
Life Sci; 2019 Sep; 232():116681. PubMed ID: 31344428
[TBL] [Abstract][Full Text] [Related]
27. Risk markers of reproductive loss in women with hyperandrogenism.
Semeniuk LM; Likhachov VK; Yuzvenko TY; Dobrovolska LМ; Makarov OG
Wiad Lek; 2018; 71(8):1550-1553. PubMed ID: 30684339
[TBL] [Abstract][Full Text] [Related]
28. The effect of cinnamon on polycystic ovary syndrome in a mouse model.
Dou L; Zheng Y; Li L; Gui X; Chen Y; Yu M; Guo Y
Reprod Biol Endocrinol; 2018 Oct; 16(1):99. PubMed ID: 30340496
[TBL] [Abstract][Full Text] [Related]
29. Hyperandrogenism and insulin resistance induce gravid uterine defects in association with mitochondrial dysfunction and aberrant reactive oxygen species production.
Hu M; Zhang Y; Guo X; Jia W; Liu G; Zhang J; Li J; Cui P; Sferruzzi-Perri AN; Han Y; Wu X; Ma H; Brännström M; Shao LR; Billig H
Am J Physiol Endocrinol Metab; 2019 May; 316(5):E794-E809. PubMed ID: 30860876
[TBL] [Abstract][Full Text] [Related]
30. Suppression of uterine and placental ferroptosis by N-acetylcysteine in a rat model of polycystic ovary syndrome.
Hu M; Zhang Y; Ma S; Li J; Wang X; Liang M; Sferruzzi-Perri AN; Wu X; Ma H; Brännström M; Shao LR; Billig H
Mol Hum Reprod; 2021 Nov; 27(12):. PubMed ID: 34850077
[TBL] [Abstract][Full Text] [Related]
31. High-fat diet induces significant metabolic disorders in a mouse model of polycystic ovary syndrome.
Lai H; Jia X; Yu Q; Zhang C; Qiao J; Guan Y; Kang J
Biol Reprod; 2014 Nov; 91(5):127. PubMed ID: 25100714
[TBL] [Abstract][Full Text] [Related]
32. The effects of metformin on uterine tissue of hyperandrogenized BALB/c mice.
Elia EM; Belgorosky D; Faut M; Vighi S; Pustovrh C; Luigi D; Motta AB
Mol Hum Reprod; 2009 Jul; 15(7):421-32. PubMed ID: 19482906
[TBL] [Abstract][Full Text] [Related]
33. Association of Oxidative Stress with Kidney Injury in a Hyperandrogenemic Female Rat Model.
Forghani N; Karimi Z; Mokhtari M; Shariati M; Masjedi F
Iran J Med Sci; 2023 Mar; 48(2):187-197. PubMed ID: 36895462
[TBL] [Abstract][Full Text] [Related]
34. Changes of The Uterine Tissue in Rats with Polycystic Ovary Syndrome Induced by Estradiol Valerate.
Mirabolghasemi G; Kamyab Z
Int J Fertil Steril; 2017; 11(1):47-55. PubMed ID: 28367305
[TBL] [Abstract][Full Text] [Related]
35. High-fat diets exaggerate endocrine and metabolic phenotypes in a rat model of DHEA-induced PCOS.
Zhang H; Yi M; Zhang Y; Jin H; Zhang W; Yang J; Yan L; Li R; Zhao Y; Qiao J
Reproduction; 2016 Apr; 151(4):431-41. PubMed ID: 26814210
[TBL] [Abstract][Full Text] [Related]
36. DHEA, DHEAS and PCOS.
Goodarzi MO; Carmina E; Azziz R
J Steroid Biochem Mol Biol; 2015 Jan; 145():213-25. PubMed ID: 25008465
[TBL] [Abstract][Full Text] [Related]
37. Shaoyao-Gancao Decoction alleviated hyperandrogenism in a letrozole-induced rat model of polycystic ovary syndrome by inhibition of NF-κB activation.
Shao YY; Chang ZP; Cheng Y; Wang XC; Zhang JP; Feng XJ; Guo YT; Liu JJ; Hou RG
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30573529
[TBL] [Abstract][Full Text] [Related]
38. Hyperandrogenism and insulin resistance modulate gravid uterine and placental ferroptosis in PCOS-like rats.
Zhang Y; Hu M; Jia W; Liu G; Zhang J; Wang B; Li J; Cui P; Li X; Lager S; Sferruzzi-Perri AN; Han Y; Liu S; Wu X; Brännström M; Shao LR; Billig H
J Endocrinol; 2020 Sep; 246(3):247-263. PubMed ID: 32590339
[TBL] [Abstract][Full Text] [Related]
39. Association of hyperandrogenemic and metabolic phenotype with carotid intima-media thickness in young women with polycystic ovary syndrome.
Vryonidou A; Papatheodorou A; Tavridou A; Terzi T; Loi V; Vatalas IA; Batakis N; Phenekos C; Dionyssiou-Asteriou A
J Clin Endocrinol Metab; 2005 May; 90(5):2740-6. PubMed ID: 15741256
[TBL] [Abstract][Full Text] [Related]
40. Adrenal androgen excess and body mass index in polycystic ovary syndrome.
Moran C; Arriaga M; Arechavaleta-Velasco F; Moran S
J Clin Endocrinol Metab; 2015 Mar; 100(3):942-50. PubMed ID: 25514100
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
